A PHASE II, OPEN-LABELED, MULTI-CENTER, RANDOMIZED CONTROLLED TRIAL OF VINBLASTINE +/- BEVACIZUMAB FOR THE TREATMENT OF CHEMOTHERAPY-NAÏVE CHILDREN WITH UNRESECTABLE OR PROGRESSIVE LOW GRADE GLIOMA (LGG)

Registry ID

1000052116

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

HOSPITAL FOR SICK CHILDREN

Start date

2019-01-10

Last update

2016-07-05

Conditions

• GLIOMA MALIGNANT

Related clinical trials

• PHASE III INTERGROUP STUDY OF TEMOZOLOMIDE ALONE VERSUS RADIOTHERAPY WITH CONCOMITANT AND ADJUVANT TEMOZOLOMIDE VERSUS RADIOTHERAPY WITH ADJUVANT PCV CHEMOTHERAPY IN PATIENTS WITH 1P/19Q CO-DELETED ANAPLASTIC GLIOMA OR LOW GRADE GLIOMA

View on source registry